Vor Biopharma (VOR) Other Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has reported Other Non-Current Assets for 7 consecutive years, with $168000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 92.91% year-over-year to $168000.0; the TTM figure through Mar 2026 stood at $168000.0 (down 92.91% YoY), while the FY2025 annual figure was $168000.0, down 93.04% from the prior year.
• Other Non-Current Assets steadied at $168000.0 in Q1 2026 per VOR's latest filing, from $168000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.8 million in Q4 2023 and bottomed at $168000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $2.1 million across 5 years, with a median of $2.4 million in 2022.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 99.42% — and 2025, when it plunged 93.04%.
• Vor Biopharma's Other Non-Current Assets stood at $2.4 million in 2022, then soared by 99.42% to $4.8 million in 2023, then tumbled by 49.85% to $2.4 million in 2024, then slumped by 93.04% to $168000.0 in 2025, then changed by 0.0% to $168000.0 in 2026.
• Business Quant data shows VOR's Other Non-Current Assets at $168000.0 in Q1 2026, $168000.0 in Q4 2025, and $269000.0 in Q3 2025.